DiscoverConversations in Drug DevelopmentNavigating the Future of EU Health Technology Assessments
Navigating the Future of EU Health Technology Assessments

Navigating the Future of EU Health Technology Assessments

Update: 2024-10-16
Share

Description

In this episode, host Dr Julie Warner is joined by experts from Decisive Consulting, Esther Nzenza, and Kevin Asher to discuss the upcoming joint clinical assessment (JCA) process set to begin in January 2025. The conversation covers the implications of the JCA for drug developers, particularly smaller companies, and emphasizes the importance of early planning and integrated evidence generation. Join us as we uncover the strategies and considerations essential for success in the ever-evolving world of health technology assessments.

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Navigating the Future of EU Health Technology Assessments

Navigating the Future of EU Health Technology Assessments

Boyds